| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 02/24/1999 | EP0897979A2 Human sdr2 cdna clone |
| 02/24/1999 | EP0897912A1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 02/24/1999 | EP0897390A1 Human tumor necrosis factor delta and epsilon |
| 02/24/1999 | EP0897302A2 Harpagoside-enriched extract from harpagophytum procumbens and processes for producing same |
| 02/24/1999 | CN1209135A Lactone derivatives of 17-beta-carboxy, carbothio and amide androstane derivatives |
| 02/24/1999 | CN1209133A Phospholipid derivatives of phosphono-carboxylic acids, prodn. and use as antiviral |
| 02/24/1999 | CN1209132A Macrocyclic compounds made from suboxide units |
| 02/24/1999 | CN1209123A New barbituric acid derivatives, processes for their prodn. and pharmaceutical agent contg. same |
| 02/24/1999 | CN1209120A 17-side chain ankynyl-and 20-oxopregna-derivatives of vitamin D, prodn. and pharmaceutical composition thereof |
| 02/24/1999 | CN1209066A Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restemosis |
| 02/24/1999 | CN1209063A Vitronection receptor antagonists |
| 02/24/1999 | CN1209060A Vitronectin receptor antagonists |
| 02/24/1999 | CN1208649A Medicated wine for treating pain in waist and lower extremities and rheumatic arthritis |
| 02/23/1999 | US5874573 Cyclic amine derivatives |
| 02/23/1999 | US5874529 Conformationally constrained backbone cyclized peptide analogs |
| 02/23/1999 | US5874459 Reducing nausea during chemotherapy; therapy for glaucoma, organ transplants |
| 02/23/1999 | US5874441 Carbocyclic and hetertocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents |
| 02/23/1999 | US5874432 Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| 02/23/1999 | US5874428 N-substituted aza-heterocyclic carboxylic acids and esters thereof |
| 02/23/1999 | US5874422 Reducing the drug side-effect while treating cardiovascular system disorder |
| 02/23/1999 | US5874300 Campylobacter jejuni antigens and methods for their production and use |
| 02/23/1999 | US5874273 Nucleic acids for encoding genes and amino acid sequences and hybridization and nucleotide sequences |
| 02/23/1999 | US5874252 Splicing variant of the Epstein-Barr virus-induced G-protein coupled receptor |
| 02/23/1999 | US5874245 Human G-protein coupled receptor (HIBCD07) |
| 02/23/1999 | US5874227 Binds to corticotropin factor; competitive binding assay for screening ligands |
| 02/23/1999 | CA2176255C Isoxazoline compounds as antiinflammatory agents |
| 02/23/1999 | CA2146007C Substituted quinuclidines |
| 02/20/1999 | CA2241429A1 Cxcr4b: a human splice variant of cxcr4 chemokine receptor |
| 02/19/1999 | CA2240631A1 Pigr-1, a member of immunoglobulin gene superfamily |
| 02/18/1999 | WO1999007855A1 Neutral sphingomyelinase |
| 02/18/1999 | WO1999007840A1 Secreted proteins and polynucleotides encoding them |
| 02/18/1999 | WO1999007681A1 2-acylaminopropanamines as tachykinin receptor antagonists |
| 02/18/1999 | WO1999007678A1 Indole derivatives as mcp-1 receptor antagonists |
| 02/18/1999 | WO1999007406A1 C1q AND COLLECTIN RECEPTOR |
| 02/18/1999 | WO1999007401A2 The use of erythropoietin and iron preparations for producing pharmaceutical combination preparations for treating rheumatic diseases |
| 02/18/1999 | WO1999007363A1 Use of the compound 2-methoxyphenyl-1-methyl-5p-methylbenzoyl-pyrrol-2-acetamido acetate for the production of an anti-inflammatory drug with prevention of gastric hypersecretion and renal impairment |
| 02/18/1999 | WO1999007351A2 Indole derivatives and their use as mcp-1 antagonists |
| 02/18/1999 | WO1998051348A3 Sustained-release delayed gels |
| 02/18/1999 | CA2300977A1 Neutral sphingomyelinase |
| 02/18/1999 | CA2298702A1 2-acylaminopropanamines as tachykinin receptor antagonists |
| 02/18/1999 | CA2298451A1 Secreted proteins and polynucleotides encoding them |
| 02/18/1999 | CA2297290A1 Chemical compounds |
| 02/18/1999 | CA2295535A1 Indole derivatives as mcp-1 receptor antagonists |
| 02/18/1999 | CA2245043A1 Ccr-3 receptor antagonists |
| 02/18/1999 | CA2245041A1 Optical active 1,4-dihydropyridine compounds as bradykinin antagonists |
| 02/17/1999 | EP0897004A2 Histidyl tRNA synthetase from Streptococcus pneumoniae (hisS) |
| 02/17/1999 | EP0896822A1 4-Aminopyrrole (3,2-d) pyrimidines as neuropeptide Y receptor antagonists |
| 02/17/1999 | EP0896622A1 Chemokine alpha 2 |
| 02/17/1999 | EP0896584A2 BIOLOGICALLY ACTIVE PROTEIN (COLLAGEN FRAGMENT HF-COLL-18/514cf) FOR INHIBITING THE GROWTH OF TUMOURS AND CAPILLARY PROFILERATIONS |
| 02/17/1999 | EP0896537A1 Preparation containing a combination of 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and n-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amide |
| 02/17/1999 | EP0896531A1 Il-8 receptor antagonists |
| 02/17/1999 | CN1208420A Antisecretory factor peptides regulating pathological permeability changes |
| 02/17/1999 | CN1208411A Benzofuran carboxamides and sulphonamides |
| 02/17/1999 | CN1208345A Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof |
| 02/17/1999 | CN1208034A Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 02/17/1999 | CN1208033A Colchicine and thiocolchicine derivatives with anti-inflammatory and muscle relaxant activities |
| 02/17/1999 | CN1207944A Rheumatism capsule |
| 02/17/1999 | CN1207930A Rheumatism plaster |
| 02/17/1999 | CN1207922A Antiphlogistic healing ointment for curing surgical infection |
| 02/16/1999 | US5872280 Respiratory system disorders |
| 02/16/1999 | US5872146 Metalloproteinases involved in connective tissue breakdown, such as collagenase, stromelysin and gelatinase and tumor necrosis factor |
| 02/16/1999 | US5872140 Vitamin D analogues |
| 02/16/1999 | US5872133 Method of regulating the immune response |
| 02/16/1999 | US5872127 Method of regulating immune function |
| 02/16/1999 | US5872118 Relaxation of skeletal muscle in spastic, hypertonic and hyperkinetic conditions |
| 02/16/1999 | US5871973 Cell division regulators |
| 02/16/1999 | US5871950 Methods of treating autoimmune diseases and transplantation rejection |
| 02/16/1999 | US5871934 Screening methods using cytokine suppressive anti-inflammatory drug (CSAID) binding proteins |
| 02/16/1999 | US5871740 Genetic engineering with proteins, antiinflammatory agents and gene expression |
| 02/16/1999 | US5871729 Superoxide dismutase-4 |
| 02/16/1999 | CA2066192C Radiation synovectomy compositions |
| 02/12/1999 | CA2239835A1 Human sdr2 cdna clone |
| 02/11/1999 | WO1999006436A1 Benzyl compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006435A1 Dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006434A1 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006433A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006432A1 Dipeptide and related compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006431A1 Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006426A1 Novel molecules of the tango-77 related protein family and uses thereof |
| 02/11/1999 | WO1999006423A1 83 human secreted proteins |
| 02/11/1999 | WO1999006410A1 Hydroxamic acid substituted fused heterocyclic metalloproteinase inhibitors |
| 02/11/1999 | WO1999006404A1 1,2,4-triazolo[4,3-b]pyrido[3,2-d]pyridazine derivatives and pharmaceutical compositions containing them |
| 02/11/1999 | WO1999006391A1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof |
| 02/11/1999 | WO1999006390A1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006361A2 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases |
| 02/11/1999 | WO1999006354A1 Il-8 receptor antagonists |
| 02/11/1999 | WO1999006340A2 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors |
| 02/11/1999 | WO1999006070A1 Switchable viscoelastic systems containing galactomannan polymers and borate |
| 02/11/1999 | WO1999006053A1 N6-substituted-adenosine-5'-uronamides as adenosine receptor modulators |
| 02/11/1999 | WO1999006041A1 SUBSTITUTED ALKANOHYDROXAMIC ACIDS AND METHOD OF REDUCING TNFα LEVELS |
| 02/11/1999 | WO1999006038A1 Fast-acting analgesic |
| 02/11/1999 | WO1999006025A1 Method and compositions for treating late phase allergic reactions and inflammatory diseases |
| 02/11/1999 | DE19734293A1 Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen Use of pharmaceutical combination preparations comprising erythropoietin and iron preparations for the treatment of rheumatic diseases |
| 02/11/1999 | CA2299055A1 Novel molecules of the tango-77 related protein family and uses thereof |
| 02/11/1999 | CA2298935A1 1,2,4-triazolo[4,3-b]pyrido[3,2-d]pyridazine derivatives and pharmaceutical compositions containing them |
| 02/11/1999 | CA2298852A1 83 human secreted proteins |
| 02/11/1999 | CA2298617A1 Acyclic metalloprotease inhibitors |
| 02/11/1999 | CA2297988A1 Hydroxamic acid substituted fused heterocyclic metalloproteinase inhibitors |
| 02/11/1999 | CA2296485A1 N6-substituted-adenosine-5'-uronamides as adenosine receptor modulators |
| 02/11/1999 | CA2295295A1 Substituted alkanohydroxamic acids and method of reducing tnf.alpha. levels |